[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-gii-amg_1976":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"entries":9},"amg_1976","Gesetz über den Verkehr mit Arzneimitteln","gii",204,0,[10,15,19,23,27,31,35,39,44,48,52,56,60,64,68,72,76,80,85,89,93,97,101,105,109,113,117,121,125,129,134,138,142,146,150,154,158,162,166,170,174,178,182,185,189,193,196,200,204,208,212,216,220,224,229,233,237,241,245,249,254,258,262,266,270,274,278,282,286,290,294,298,302,306,310,314,319,323,327,331,335,339,343,347,351,355,359,363,367,371,375,379,384,388,392,397,401,405,409,413,417,421,425,429,433,437,441,446,450,454,458,462,466,470,474,479,482,487,491,495,499,503,507,511,516,519,523,528,532,536,540,544,548,552,556,560,565,569,573,577,581,585,589,592,596,600,604,608,612,617,620,624,628,633,636,639,642,645,648,651,654,657,660,663,666,669,672,675,678,681,684,687,690,693,696,699,702,705,708,711,714,717,720,723,727,730,733,736,739,743,747,751,755,759,763,767,771,775,779,783,787,792,796,800],{"norm_key":11,"title":12,"chapter":13,"slug":14},"§ 1","Zweck des Gesetzes","Zweck des Gesetzes und Begriffsbestimmungen, Anwendungsbereich","1",{"norm_key":16,"title":17,"chapter":13,"slug":18},"§ 2","Arzneimittelbegriff","2",{"norm_key":20,"title":21,"chapter":13,"slug":22},"§ 3","Stoffbegriff","3",{"norm_key":24,"title":25,"chapter":13,"slug":26},"§ 4","Sonstige Begriffsbestimmungen","4",{"norm_key":28,"title":29,"chapter":13,"slug":30},"§ 4a","Ausnahme vom Anwendungsbereich","4a",{"norm_key":32,"title":33,"chapter":13,"slug":34},"§ 4b","Sondervorschriften für Arzneimittel für neuartige Therapien","4b",{"norm_key":36,"title":37,"chapter":13,"slug":38},"§ 4c","Indikationsbezogenes Register für Arzneimittel für neuartige Therapien","4c",{"norm_key":40,"title":41,"chapter":42,"slug":43},"§ 5","Verbot bedenklicher Arzneimittel","Anforderungen an die Arzneimittel","5",{"norm_key":45,"title":46,"chapter":42,"slug":47},"§ 6","Verbote zum Schutz der Gesundheit, Verordnungsermächtigungen","6",{"norm_key":49,"title":50,"chapter":42,"slug":51},"§ 7","Radioaktive und mit ionisierenden Strahlen behandelte Arzneimittel","7",{"norm_key":53,"title":54,"chapter":42,"slug":55},"§ 8","Verbote zum Schutz vor Täuschung","8",{"norm_key":57,"title":58,"chapter":42,"slug":59},"§ 9","Der Verantwortliche für das Inverkehrbringen","9",{"norm_key":61,"title":62,"chapter":42,"slug":63},"§ 10","Kennzeichnung","10",{"norm_key":65,"title":66,"chapter":42,"slug":67},"§ 10a","Kennzeichnung von Prüf- und Hilfspräparaten für klinische Prüfungen","10a",{"norm_key":69,"title":70,"chapter":42,"slug":71},"§ 11","Packungsbeilage","11",{"norm_key":73,"title":74,"chapter":42,"slug":75},"§ 11a","Fachinformation","11a",{"norm_key":77,"title":78,"chapter":42,"slug":79},"§ 12","Ermächtigung für die Kennzeichnung, die Packungsbeilage und die Packungsgrößen","12",{"norm_key":81,"title":82,"chapter":83,"slug":84},"§ 13","Herstellungserlaubnis","Herstellung von Arzneimitteln","13",{"norm_key":86,"title":87,"chapter":83,"slug":88},"§ 14","Entscheidung über die Herstellungserlaubnis","14",{"norm_key":90,"title":91,"chapter":83,"slug":92},"§ 15","Sachkenntnis","15",{"norm_key":94,"title":95,"chapter":83,"slug":96},"§ 16","Begrenzung der Herstellungserlaubnis","16",{"norm_key":98,"title":99,"chapter":83,"slug":100},"§ 17","Fristen für die Erteilung","17",{"norm_key":102,"title":103,"chapter":83,"slug":104},"§ 18","Rücknahme, Widerruf, Ruhen","18",{"norm_key":106,"title":107,"chapter":83,"slug":108},"§ 19","Verantwortungsbereiche","19",{"norm_key":110,"title":111,"chapter":83,"slug":112},"§ 20","Anzeigepflichten","20",{"norm_key":114,"title":115,"chapter":83,"slug":116},"§ 20a","Geltung für Wirkstoffe und andere Stoffe","20a",{"norm_key":118,"title":119,"chapter":83,"slug":120},"§ 20b","Erlaubnis für die Gewinnung von Gewebe und die Laboruntersuchungen","20b",{"norm_key":122,"title":123,"chapter":83,"slug":124},"§ 20c","Erlaubnis für die Be- oder Verarbeitung, Konservierung, Prüfung, Lagerung oder das Inverkehrbringen von Gewebe oder Gewebezubereitungen","20c",{"norm_key":126,"title":127,"chapter":83,"slug":128},"§ 20d","Ausnahme von der Erlaubnispflicht für Gewebe und Gewebezubereitungen","20d",{"norm_key":130,"title":131,"chapter":132,"slug":133},"§ 21","Zulassungspflicht","Zulassung der Arzneimittel","21",{"norm_key":135,"title":136,"chapter":132,"slug":137},"§ 21a","Genehmigung von Gewebezubereitungen","21a",{"norm_key":139,"title":140,"chapter":132,"slug":141},"§ 22","Zulassungsunterlagen","22",{"norm_key":143,"title":144,"chapter":132,"slug":145},"§ 24","Sachverständigengutachten","24",{"norm_key":147,"title":148,"chapter":132,"slug":149},"§ 24a","Verwendung von Unterlagen eines Vorantragstellers","24a",{"norm_key":151,"title":152,"chapter":132,"slug":153},"§ 24b","Zulassung eines Generikums, Unterlagenschutz","24b",{"norm_key":155,"title":156,"chapter":132,"slug":157},"§ 24c","Nachforderungen","24c",{"norm_key":159,"title":160,"chapter":132,"slug":161},"§ 24d","Allgemeine Verwertungsbefugnis","24d",{"norm_key":163,"title":164,"chapter":132,"slug":165},"§ 25","Entscheidung über die Zulassung","25",{"norm_key":167,"title":168,"chapter":132,"slug":169},"§ 25a","Vorprüfung","25a",{"norm_key":171,"title":172,"chapter":132,"slug":173},"§ 25b","Verfahren der gegenseitigen Anerkennung und dezentralisiertes Verfahren","25b",{"norm_key":175,"title":176,"chapter":132,"slug":177},"§ 25c","Maßnahmen der zuständigen Bundesoberbehörde zu Entscheidungen oder Beschlüssen der Europäischen Gemeinschaft oder der Europäischen Union","25c",{"norm_key":179,"title":180,"chapter":132,"slug":181},"§ 26","Arzneimittelprüfrichtlinien","26",{"norm_key":183,"title":99,"chapter":132,"slug":184},"§ 27","27",{"norm_key":186,"title":187,"chapter":132,"slug":188},"§ 28","Auflagenbefugnis","28",{"norm_key":190,"title":191,"chapter":132,"slug":192},"§ 29","Anzeigepflicht, Neuzulassung","29",{"norm_key":194,"title":103,"chapter":132,"slug":195},"§ 30","30",{"norm_key":197,"title":198,"chapter":132,"slug":199},"§ 31","Erlöschen, Verlängerung","31",{"norm_key":201,"title":202,"chapter":132,"slug":203},"§ 32","Staatliche Chargenprüfung","32",{"norm_key":205,"title":206,"chapter":132,"slug":207},"§ 33","Aufwendungsersatz und Entgelte","33",{"norm_key":209,"title":210,"chapter":132,"slug":211},"§ 34","Information der Öffentlichkeit","34",{"norm_key":213,"title":214,"chapter":132,"slug":215},"§ 35","Ermächtigungen zur Zulassung und Freistellung","35",{"norm_key":217,"title":218,"chapter":132,"slug":219},"§ 36","Ermächtigung für Standardzulassungen","36",{"norm_key":221,"title":222,"chapter":132,"slug":223},"§ 37","Genehmigung der Europäischen Gemeinschaft oder der Europäischen Union für das Inverkehrbringen, Zulassungen von Arzneimitteln aus anderen Staaten","37",{"norm_key":225,"title":226,"chapter":227,"slug":228},"§ 38","Registrierung homöopathischer Arzneimittel","Registrierung von Arzneimitteln","38",{"norm_key":230,"title":231,"chapter":227,"slug":232},"§ 39","Entscheidung über die Registrierung homöopathischer Arzneimittel, Verfahrensvorschriften","39",{"norm_key":234,"title":235,"chapter":227,"slug":236},"§ 39a","Registrierung traditioneller pflanzlicher Arzneimittel","39a",{"norm_key":238,"title":239,"chapter":227,"slug":240},"§ 39b","Registrierungsunterlagen für traditionelle pflanzliche Arzneimittel","39b",{"norm_key":242,"title":243,"chapter":227,"slug":244},"§ 39c","Entscheidung über die Registrierung traditioneller pflanzlicher Arzneimittel","39c",{"norm_key":246,"title":247,"chapter":227,"slug":248},"§ 39d","Sonstige Verfahrensvorschriften für traditionelle pflanzliche Arzneimittel","39d",{"norm_key":250,"title":251,"chapter":252,"slug":253},"§ 40","Verfahren zur Genehmigung einer klinischen Prüfung","Schutz des Menschen bei der klinischen Prüfung","40",{"norm_key":255,"title":256,"chapter":252,"slug":257},"§ 40a","Allgemeine Voraussetzungen für die klinische Prüfung","40a",{"norm_key":259,"title":260,"chapter":252,"slug":261},"§ 40b","Besondere Voraussetzungen für die klinische Prüfung","40b",{"norm_key":263,"title":264,"chapter":252,"slug":265},"§ 40c","Verfahren bei Hinzufügung eines Mitgliedstaates, bei Änderungen sowie bei Bewertungsverfahren","40c",{"norm_key":267,"title":268,"chapter":252,"slug":269},"§ 40d","Besondere Pflichten des Prüfers, des Sponsors und der zuständigen Bundesoberbehörde","40d",{"norm_key":271,"title":272,"chapter":252,"slug":273},"§ 41","Stellungnahme der Ethik-Kommission","41",{"norm_key":275,"title":276,"chapter":252,"slug":277},"§ 41a","Registrierungsverfahren für Ethik-Kommissionen","41a",{"norm_key":279,"title":280,"chapter":252,"slug":281},"§ 41b","Verfahrensordnung und Geschäftsverteilungsplan","41b",{"norm_key":283,"title":284,"chapter":252,"slug":285},"§ 41c","Spezialisierte Ethik-Kommission für besondere Verfahren","41c",{"norm_key":287,"title":288,"chapter":252,"slug":289},"§ 41d","Richtlinien zur Bewertung klinischer Prüfungen durch Ethik-Kommissionen","41d",{"norm_key":291,"title":292,"chapter":252,"slug":293},"§ 42","Korrekturmaßnahmen","42",{"norm_key":295,"title":296,"chapter":252,"slug":297},"§ 42a","Datenschutz","42a",{"norm_key":299,"title":300,"chapter":252,"slug":301},"§ 42b","Veröffentlichung der Ergebnisse klinischer Prüfungen","42b",{"norm_key":303,"title":304,"chapter":252,"slug":305},"§ 42c","Inspektionen","42c",{"norm_key":307,"title":308,"chapter":252,"slug":309},"§ 42d","Standardvertragsklauseln für die Durchführung klinischer Prüfungen","42d",{"norm_key":311,"title":312,"chapter":252,"slug":313},"§ 42e","Empfehlungen für von nichtkommerziellen Sponsoren durchgeführte klinische Prüfungen ohne wirtschaftliche Zwecksetzung","42e",{"norm_key":315,"title":316,"chapter":317,"slug":318},"§ 43","Apothekenpflicht","Abgabe von Arzneimitteln","43",{"norm_key":320,"title":321,"chapter":317,"slug":322},"§ 44","Ausnahme von der Apothekenpflicht","44",{"norm_key":324,"title":325,"chapter":317,"slug":326},"§ 45","Ermächtigung zu weiteren Ausnahmen von der Apothekenpflicht","45",{"norm_key":328,"title":329,"chapter":317,"slug":330},"§ 46","Ermächtigung zur Ausweitung der Apothekenpflicht","46",{"norm_key":332,"title":333,"chapter":317,"slug":334},"§ 47","Vertriebsweg","47",{"norm_key":336,"title":337,"chapter":317,"slug":338},"§ 47a","Sondervertriebsweg, Nachweispflichten","47a",{"norm_key":340,"title":341,"chapter":317,"slug":342},"§ 47b","Sondervertriebsweg Diamorphin","47b",{"norm_key":344,"title":345,"chapter":317,"slug":346},"§ 48","Verschreibungspflicht","48",{"norm_key":348,"title":349,"chapter":317,"slug":350},"§ 49",null,"49",{"norm_key":352,"title":353,"chapter":317,"slug":354},"§ 50","Einzelhandel mit freiverkäuflichen Arzneimitteln","50",{"norm_key":356,"title":357,"chapter":317,"slug":358},"§ 51","Abgabe im Reisegewerbe","51",{"norm_key":360,"title":361,"chapter":317,"slug":362},"§ 52","Verbot der Selbstbedienung","52",{"norm_key":364,"title":365,"chapter":317,"slug":366},"§ 52a","Großhandel mit Arzneimitteln","52a",{"norm_key":368,"title":369,"chapter":317,"slug":370},"§ 52b","Bereitstellung von Arzneimitteln","52b",{"norm_key":372,"title":373,"chapter":317,"slug":374},"§ 52c","Arzneimittelvermittlung","52c",{"norm_key":376,"title":377,"chapter":317,"slug":378},"§ 53","Anhörung von Sachverständigen","53",{"norm_key":380,"title":381,"chapter":382,"slug":383},"§ 54","Betriebsverordnungen","Sicherung und Kontrolle der Qualität","54",{"norm_key":385,"title":386,"chapter":382,"slug":387},"§ 55","Arzneibuch","55",{"norm_key":389,"title":390,"chapter":382,"slug":391},"§ 55a","Amtliche Sammlung von Untersuchungsverfahren","55a",{"norm_key":393,"title":394,"chapter":395,"slug":396},"§ 62","Organisation","Beobachtung, Sammlung und Auswertung von Arzneimittelrisiken","62",{"norm_key":398,"title":399,"chapter":395,"slug":400},"§ 63","Stufenplan","63",{"norm_key":402,"title":403,"chapter":395,"slug":404},"§ 63a","Stufenplanbeauftragter","63a",{"norm_key":406,"title":407,"chapter":395,"slug":408},"§ 63b","Allgemeine Pharmakovigilanz-Pflichten des Inhabers der Zulassung","63b",{"norm_key":410,"title":411,"chapter":395,"slug":412},"§ 63c","Dokumentations- und Meldepflichten des Inhabers der Zulassung bei Verdachtsfällen von Nebenwirkungen","63c",{"norm_key":414,"title":415,"chapter":395,"slug":416},"§ 63d","Regelmäßige aktualisierte Unbedenklichkeitsberichte","63d",{"norm_key":418,"title":419,"chapter":395,"slug":420},"§ 63e","Europäisches Verfahren","63e",{"norm_key":422,"title":423,"chapter":395,"slug":424},"§ 63f","Allgemeine Voraussetzungen für nichtinterventionelle Unbedenklichkeitsstudien","63f",{"norm_key":426,"title":427,"chapter":395,"slug":428},"§ 63g","Besondere Voraussetzungen für angeordnete nichtinterventionelle Unbedenklichkeitsstudien","63g",{"norm_key":430,"title":431,"chapter":395,"slug":432},"§ 63i","Dokumentations- und Meldepflichten bei Blut- und Gewebezubereitungen und Gewebe","63i",{"norm_key":434,"title":435,"chapter":395,"slug":436},"§ 63j","Dokumentations- und Meldepflichten der behandelnden Person für nicht zulassungs- oder genehmigungspflichtige Arzneimittel für neuartige Therapien","63j",{"norm_key":438,"title":439,"chapter":395,"slug":440},"§ 63k","Ausnahmen","63k",{"norm_key":442,"title":443,"chapter":444,"slug":445},"§ 64","Durchführung der Überwachung","Überwachung","64",{"norm_key":447,"title":448,"chapter":444,"slug":449},"§ 65","Probenahme","65",{"norm_key":451,"title":452,"chapter":444,"slug":453},"§ 66","Duldungs- und Mitwirkungspflicht","66",{"norm_key":455,"title":456,"chapter":444,"slug":457},"§ 67","Allgemeine Anzeigepflicht","67",{"norm_key":459,"title":460,"chapter":444,"slug":461},"§ 67a","Datenbankgestütztes Informationssystem","67a",{"norm_key":463,"title":464,"chapter":444,"slug":465},"§ 67b","EU-Kompendium der Gewebeeinrichtungen, EU-Kompendium der Gewebe- und Zellprodukte, Unterrichtungspflichten","67b",{"norm_key":467,"title":468,"chapter":444,"slug":469},"§ 68","Mitteilungs- und Unterrichtungspflichten","68",{"norm_key":471,"title":472,"chapter":444,"slug":473},"§ 69","Maßnahmen der zuständigen Behörden","69",{"norm_key":475,"title":476,"chapter":477,"slug":478},"§ 70","Anwendung und Vollzug des Gesetzes","Sondervorschriften für Bundeswehr, Bundespolizei, Bereitschaftspolizei, Zivilschutz","70",{"norm_key":480,"title":439,"chapter":477,"slug":481},"§ 71","71",{"norm_key":483,"title":484,"chapter":485,"slug":486},"§ 72","Einfuhrerlaubnis","Einfuhr und Ausfuhr","72",{"norm_key":488,"title":489,"chapter":485,"slug":490},"§ 72a","Zertifikate","72a",{"norm_key":492,"title":493,"chapter":485,"slug":494},"§ 72b","Einfuhrerlaubnis und Zertifikate für Gewebe und bestimmte Gewebezubereitungen","72b",{"norm_key":496,"title":497,"chapter":485,"slug":498},"§ 72c","Einmalige Einfuhr von Gewebe oder Gewebezubereitungen","72c",{"norm_key":500,"title":501,"chapter":485,"slug":502},"§ 73","Verbringungsverbot","73",{"norm_key":504,"title":505,"chapter":485,"slug":506},"§ 73a","Ausfuhr","73a",{"norm_key":508,"title":509,"chapter":485,"slug":510},"§ 74","Mitwirkung von Zolldienststellen","74",{"norm_key":512,"title":513,"chapter":514,"slug":515},"§ 74a","Informationsbeauftragter","Informationsbeauftragter, Pharmaberater","74a",{"norm_key":517,"title":91,"chapter":514,"slug":518},"§ 75","75",{"norm_key":520,"title":521,"chapter":514,"slug":522},"§ 76","Pflichten","76",{"norm_key":524,"title":525,"chapter":526,"slug":527},"§ 77","Zuständige Bundesoberbehörde,Verordnungsermächtigung","Bestimmung der zuständigen Bundesoberbehörden und sonstige Bestimmungen","77",{"norm_key":529,"title":530,"chapter":526,"slug":531},"§ 77a","Unabhängigkeit und Transparenz","77a",{"norm_key":533,"title":534,"chapter":526,"slug":535},"§ 78","Preise","78",{"norm_key":537,"title":538,"chapter":526,"slug":539},"§ 79","Ausnahmeermächtigungen für Krisenzeiten","79",{"norm_key":541,"title":542,"chapter":526,"slug":543},"§ 80","Ermächtigung für Verfahrens- und Härtefallregelungen","80",{"norm_key":545,"title":546,"chapter":526,"slug":547},"§ 81","Verhältnis zu anderen Gesetzen","81",{"norm_key":549,"title":550,"chapter":526,"slug":551},"§ 82","Allgemeine Verwaltungsvorschriften","82",{"norm_key":553,"title":554,"chapter":526,"slug":555},"§ 83","Angleichung an das Recht der Europäischen Union","83",{"norm_key":557,"title":558,"chapter":526,"slug":559},"§ 83a","Rechtsverordnungen in bestimmten Fällen","83a",{"norm_key":561,"title":562,"chapter":563,"slug":564},"§ 84","Gefährdungshaftung","Haftung für Arzneimittelschäden","84",{"norm_key":566,"title":567,"chapter":563,"slug":568},"§ 84a","Auskunftsanspruch","84a",{"norm_key":570,"title":571,"chapter":563,"slug":572},"§ 85","Mitverschulden","85",{"norm_key":574,"title":575,"chapter":563,"slug":576},"§ 86","Umfang der Ersatzpflicht bei Tötung","86",{"norm_key":578,"title":579,"chapter":563,"slug":580},"§ 87","Umfang der Ersatzpflicht bei Körperverletzung","87",{"norm_key":582,"title":583,"chapter":563,"slug":584},"§ 88","Höchstbeträge","88",{"norm_key":586,"title":587,"chapter":563,"slug":588},"§ 89","Schadensersatz durch Geldrenten","89",{"norm_key":590,"title":349,"chapter":563,"slug":591},"§ 90","90",{"norm_key":593,"title":594,"chapter":563,"slug":595},"§ 91","Weitergehende Haftung","91",{"norm_key":597,"title":598,"chapter":563,"slug":599},"§ 92","Unabdingbarkeit","92",{"norm_key":601,"title":602,"chapter":563,"slug":603},"§ 93","Mehrere Ersatzpflichtige","93",{"norm_key":605,"title":606,"chapter":563,"slug":607},"§ 94","Deckungsvorsorge","94",{"norm_key":609,"title":610,"chapter":563,"slug":611},"§ 94a","Örtliche Zuständigkeit","94a",{"norm_key":613,"title":614,"chapter":615,"slug":616},"§ 95","Strafvorschriften","Straf- und Bußgeldvorschriften","95",{"norm_key":618,"title":614,"chapter":615,"slug":619},"§ 96","96",{"norm_key":621,"title":622,"chapter":615,"slug":623},"§ 97","Bußgeldvorschriften","97",{"norm_key":625,"title":626,"chapter":615,"slug":627},"§ 98","Einziehung","98",{"norm_key":629,"title":630,"chapter":631,"slug":632},"§ 99","Arzneimittelgesetz 1961","Überleitungsvorschriften aus Anlass des Gesetzes zur Neuordnung des Arzneimittelrechts","99",{"norm_key":634,"title":349,"chapter":631,"slug":635},"§ 100","100",{"norm_key":637,"title":349,"chapter":631,"slug":638},"§ 101","101",{"norm_key":640,"title":349,"chapter":631,"slug":641},"§ 102","102",{"norm_key":643,"title":349,"chapter":631,"slug":644},"§ 102a","102a",{"norm_key":646,"title":349,"chapter":631,"slug":647},"§ 103","103",{"norm_key":649,"title":349,"chapter":631,"slug":650},"§ 104","104",{"norm_key":652,"title":349,"chapter":631,"slug":653},"§ 105","105",{"norm_key":655,"title":349,"chapter":631,"slug":656},"§ 105a","105a",{"norm_key":658,"title":349,"chapter":631,"slug":659},"§ 105b","105b",{"norm_key":661,"title":349,"chapter":631,"slug":662},"§ 106","106",{"norm_key":664,"title":349,"chapter":631,"slug":665},"§ 107","107",{"norm_key":667,"title":349,"chapter":631,"slug":668},"§ 108","108",{"norm_key":670,"title":349,"chapter":631,"slug":671},"§ 108a","108a",{"norm_key":673,"title":349,"chapter":631,"slug":674},"§ 108b","108b",{"norm_key":676,"title":349,"chapter":631,"slug":677},"§ 109","109",{"norm_key":679,"title":349,"chapter":631,"slug":680},"§ 109a","109a",{"norm_key":682,"title":349,"chapter":631,"slug":683},"§ 110","110",{"norm_key":685,"title":349,"chapter":631,"slug":686},"§ 111","111",{"norm_key":688,"title":349,"chapter":631,"slug":689},"§ 112","112",{"norm_key":691,"title":349,"chapter":631,"slug":692},"§ 114","114",{"norm_key":694,"title":349,"chapter":631,"slug":695},"§ 115","115",{"norm_key":697,"title":349,"chapter":631,"slug":698},"§ 116","116",{"norm_key":700,"title":349,"chapter":631,"slug":701},"§ 117","117",{"norm_key":703,"title":349,"chapter":631,"slug":704},"§ 118","118",{"norm_key":706,"title":349,"chapter":631,"slug":707},"§ 119","119",{"norm_key":709,"title":349,"chapter":631,"slug":710},"§ 120","120",{"norm_key":712,"title":349,"chapter":631,"slug":713},"§ 121","121",{"norm_key":715,"title":349,"chapter":631,"slug":716},"§ 122","122",{"norm_key":718,"title":349,"chapter":631,"slug":719},"§ 123","123",{"norm_key":721,"title":349,"chapter":631,"slug":722},"§ 124","124",{"norm_key":724,"title":349,"chapter":725,"slug":726},"§ 127","Übergangsvorschriften aus Anlass des Zweiten Gesetzes zur Änderung des Arzneimittelgesetzes","127",{"norm_key":728,"title":349,"chapter":725,"slug":729},"§ 128","128",{"norm_key":731,"title":349,"chapter":725,"slug":732},"§ 129","129",{"norm_key":734,"title":349,"chapter":725,"slug":735},"§ 130","130",{"norm_key":737,"title":349,"chapter":725,"slug":738},"§ 131","131",{"norm_key":740,"title":349,"chapter":741,"slug":742},"§ 132","Übergangsvorschriften aus Anlass des Fünften Gesetzes zur Änderung des Arzneimittelgesetzes","132",{"norm_key":744,"title":349,"chapter":745,"slug":746},"§ 134","Übergangsvorschriften aus Anlass des Transfusionsgesetzes","134",{"norm_key":748,"title":349,"chapter":749,"slug":750},"§ 135","Übergangsvorschriften aus Anlass des Achten Gesetzes zur Änderung des Arzneimittelgesetzes","135",{"norm_key":752,"title":349,"chapter":753,"slug":754},"§ 136","Übergangsvorschriften aus Anlass des Zehnten Gesetzes zur Änderung des Arzneimittelgesetzes","136",{"norm_key":756,"title":349,"chapter":757,"slug":758},"§ 138","Übergangsvorschriften aus Anlass des Zwölften Gesetzes zur Änderung des Arzneimittelgesetzes","138",{"norm_key":760,"title":349,"chapter":761,"slug":762},"§ 139","Übergangsvorschriften aus Anlass des Ersten Gesetzes zur Änderung des Transfusionsgesetzes und arzneimittelrechtlicher Vorschriften","139",{"norm_key":764,"title":349,"chapter":765,"slug":766},"§ 141","Übergangsvorschriften aus Anlass des Vierzehnten Gesetzes zur Änderung des Arzneimittelgesetzes","141",{"norm_key":768,"title":769,"chapter":349,"slug":770},"§ 142","Übergangsvorschriften aus Anlass des Gewebegesetzes","142",{"norm_key":772,"title":773,"chapter":349,"slug":774},"§ 142a","Übergangs- und Bestandsschutzvorschrift aus Anlass des Gesetzes zur Umsetzung der Richtlinien (EU) 2015\u002F566 und (EU) 2015\u002F565 zur Einfuhr und zur Kodierung menschlicher Gewebe und Gewebezubereitungen","142a",{"norm_key":776,"title":777,"chapter":349,"slug":778},"§ 142b","Übergangsvorschrift aus Anlass des Gesetzes zur Fortschreibung der Vorschriften für Blut- und Gewebezubereitungen und zur Änderung anderer Vorschriften","142b",{"norm_key":780,"title":349,"chapter":781,"slug":782},"§ 144","Übergangsvorschriften aus Anlass des Gesetzes zur Änderung arzneimittelrechtlicher und anderer Vorschriften","144",{"norm_key":784,"title":785,"chapter":349,"slug":786},"§ 145","Übergangsvorschriften aus Anlass des Gesetzes zur Neuordnung des Arzneimittelmarktes","145",{"norm_key":788,"title":789,"chapter":790,"slug":791},"§ 146","Übergangsvorschriften aus Anlass des Zweiten Gesetzes zur Änderung arzneimittelrechtlicher und anderer Vorschriften","Übergangsvorschrift","146",{"norm_key":793,"title":794,"chapter":790,"slug":795},"§ 147","Übergangsvorschrift aus Anlass des Dritten Gesetzes zur Änderung arzneimittelrechtlicher und anderer Vorschriften","147",{"norm_key":797,"title":798,"chapter":790,"slug":799},"§ 148","Übergangsvorschrift aus Anlass des Vierten Gesetzes zur Änderung arzneimittelrechtlicher und anderer Vorschriften sowie des Gesetzes zum Erlass eines Tierarzneimittelgesetzes und zur Anpassung arzneimittelrechtlicher und anderer Vorschriften","148",{"norm_key":801,"title":802,"chapter":790,"slug":349},"Anlage","(zu § 6)"]